Unlike other types of kidney cancer, RMC poses a significant challenge with less than 5 percent of patients surviving beyond three years using standard treatments. However, recent research offers new hope.

Though some may not realize it, breast cancer can occur in men. Read about a study examining the exclusion of men from Phase III breast cancer clinical trials.

The genetic condition of sickle cell disease (SCD) results when sickle cell genes are inherited from each parent. We connected with Dr. Seethal Jacob about a study on maintaining an immune response against pneumococcal bacteria in children with SCD.

During the COVID-19 pandemic there was a large drop in cancer screenings. This reduction could potentially decrease the chances of detecting many cancers at earlier stages and possibly lead to a greater amount of suffering from undiagnosed or late-stage diagnoses.

As the most commonly occurring blood disorder in the world, sickle cell trait primarily impacts those in the BIPOC community with African ancestry. We connected with Dr. Pavlos Msaouel about a study on high-intensity exercise in those with sickle cell trait.

New research from Heinz Ludwig, MD et al explores the global interrelations between Multiple Myeloma (MM) mortality and countries’ economic resources, patient empowerment, and health access and quality. The study is intended to inform about the associations between these factors, and to improve diagnosis, management, and outcome of patients globally.

Black American women have less breast cancer but die at higher rates than our white counterparts. Why is there a disparity?

Studies centering on vaccinations for myeloma patients have been limited in the past due to their low participation rate in trials coupled with negligent measures of patient outcomes. Learn about compilation of vaccination data.